نتایج جستجو برای: proprotein convertase

تعداد نتایج: 3949  

2016
Elise F. Villard Aurélie Thedrez Jorg Blankenstein Mikaël Croyal Thi-Thu-Trang Tran Bruno Poirier Jean-Christophe Le Bail Stéphane Illiano Estelle Nobécourt Michel Krempf Dirk J. Blom A. David Marais Philip Janiak Anthony J. Muslin Etienne Guillot Gilles Lambert

To elucidate how the proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor alirocumab modulates lipoprotein(a) [Lp(a)] plasma levels, the authors performed a series of Lp(a) uptake studies in primary human hepatocytes and dermal fibroblasts and measured Lp(a) secretion from human hepatocytes. They found that Lp(a) cellular uptake occurred in a low-density lipoprotein receptor-independ...

Journal: :American journal of physiology. Endocrinology and metabolism 2013
Nicole E Cyr Anika M Toorie Jennifer S Steger Matthew M Sochat Samantha Hyner Mario Perello Ronald Stuart Eduardo A Nillni

Protein posttranslational processing is a cellular mechanism fundamental to the generation of bioactive peptides, including the anorectic α-melanocyte-stimulating hormone (α-MSH) and thyrotropin-releasing hormone (TRH) peptides produced in the hypothalamic arcuate (ARC) and paraventricular (PVN) nuclei, respectively. Neuropeptide Y (NPY) promotes positive energy balance in part by suppressing α...

Journal: :Proteins 2010
Robert A Pearlstein Qi-Ying Hu Jing Zhou David Yowe Julian Levell Bethany Dale Virendar K Kaushik Doug Daniels Susan Hanrahan Woody Sherman Robert Abel

LDL cholesterol (LDL-C) is cleared from plasma via cellular uptake and internalization processes that are largely mediated by the low-density lipoprotein cholesterol receptor (LDL-R). LDL-R is targeted for lysosomal degradation by association with proprotein convertase subtilisin-kexin type 9 (PCSK9). Gain of function mutations in PCSK9 can result in excessive loss of receptors and dyslipidemia...

Journal: :Clinical chemistry 2007
William E Alborn Guoqing Cao Holly E Careskey Yue-Wei Qian Danise R Subramaniam Julian Davies Elaine M Conner Robert J Konrad

BACKGROUND Proprotein convertase subtilisin kexin type 9 (PCSK9) is gaining attention as a key regulator of serum LDL-cholesterol (LDLC). This novel serine protease causes the degradation of hepatic LDL receptors by an unknown mechanism. In humans, gain-of-function mutations in the PCSK9 gene cause a form of familial hypercholesterolemia, whereas loss-of-function mutations result in significant...

2012
Xi Ai Paul Fischer Oksana C Palyha Douglas Wisniewski Brian Hubbard Karen Akinsanya Alison M Strack Anka G Ehrhardt

The function of a particular protein is dependent upon its localization and milieu. The ability to track the "fate" of a protein is a valuable tool to elucidate its function. We present the use of HaloTag technology to study the localization and fate of human Proprotein Convertase Subtilisin-like Kexin type 9 (PCSK9).The role of PCSK9 in the regulation of circulating low density lipoprotein-cho...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید